Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia

Published:2021-09-02 Issue:9 Volume:14 Page:795-807
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Ceppi Francesco¹,Rizzati Frida¹,Colombini Antonella²,Conter Valentino²,Cazzaniga Giovanni³⁴^ORCID

Affiliation:

1. Pediatric Hematology-Oncology Unit, Division of Pediatrics, Woman-Mother-Child Department, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland

2. Pediatric Hematology-Oncology, University Milano Bicocca, Fondazione MBBM/Ospedale San Gerardo, Monza, Italy

3. Centro Ricerca Tettamanti, Pediatrics, School of Medicine, University of Milano Bicocca, Fondazione MBBM/Ospedale San Gerardo, Monza, Italy

4. Medical Genetics, School of Medicine, University of Milano Bicocca, Monza, Italy

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2021.1967137

Reference102 articles.

1. Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0331

2. Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica, Online ahead of print; 2020. p. 11.

3. Pediatric acute lymphoblastic leukemia

4. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

5. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Have we been qualifying measurable residual disease correctly?;Leukemia;2023-09-13

2. Optimizing Pediatric Leukemia Care in Countries With Limited Resources;Journal of Clinical Oncology;2023-07-01

3. Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studies;European Journal of Cancer;2022-11

4. Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia;Journal of Cancer Research and Clinical Oncology;2022-08-02